Mesh.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Mesh.i » - entrée « Radioligand Assay »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Radioisotopes < Radioligand Assay < Radionuclide Imaging  Facettes :

List of bibliographic references indexed by Radioligand Assay

Number of relevant bibliographic references: 18.
Ident.Authors (with country if any)Title
000920 (2014) Vincent A. Jourdain [Canada] ; Nicolas Morin [Canada] ; Marc Morissette [Canada] ; Laurent Grégoire [Canada] ; Thérèse Di Paolo [Canada]Subthalamotomy-induced changes in dopamine receptors in parkinsonian monkeys.
000D42 (2013) Nicolas Morin [Canada] ; Laurent Grégoire ; Marc Morissette ; Sandrine Desrayaud ; Baltazar Gomez-Mancilla ; Fabrizio Gasparini ; Thérèse Di PaoloMPEP, an mGlu5 receptor antagonist, reduces the development of L-DOPA-induced motor complications in de novo parkinsonian monkeys: biochemical correlates.
000E29 (2013) Nicolas Morin [Canada] ; Marc Morissette ; Laurent Grégoire ; Baltazar Gomez-Mancilla ; Fabrizio Gasparini ; Thérèse Di PaoloChronic treatment with MPEP, an mGlu5 receptor antagonist, normalizes basal ganglia glutamate neurotransmission in L-DOPA-treated parkinsonian monkeys.
001288 (2012) Stuart W S. Macdonald [Canada] ; Sari Karlsson ; Anna Rieckmann ; Lars Nyberg ; Lars B CkmanAging-related increases in behavioral variability: relations to losses of dopamine D1 receptors.
002081 (2009) Pershia Samadi [Canada] ; Alex Rajput [Canada] ; Frédéric Calon [Canada] ; Laurent Gregoire [Canada] ; Oleh Homykiewicz [Canada, Autriche] ; Ali H. Rajput [Canada] ; Thèrèse Di Paolo [Canada]Metabotropic Glutamate Receptor II in the Brains of Parkinsonian Patients
002999 (2005) Philip Seeman [Canada] ; Françoise Ko ; Matth Us Willeit ; Patrick Mccormick ; Nathalie GinovartAntiparkinson concentrations of pramipexole and PHNO occupy dopamine D2(high) and D3(high) receptors.
002D16 (2004) D. J. Doudet [Canada] ; M. L. Cornfeldt [États-Unis] ; C. R. Honey [Canada] ; A. W. Schweikert [États-Unis] ; R. C. Allen [États-Unis]PET imaging of implanted human retinal pigment epithelial cells in the MPTP-induced primate model of parkinson's disease
002D61 (2003) Doris J. Doudet [Canada] ; James E. HoldenRaclopride studies of dopamine release: dependence on presynaptic integrity.
002D75 (2003) Frédéric Calon [Canada] ; Ali H. Rajput ; Oleh Hornykiewicz ; Paul J. Bédard ; Thérèse Di PaoloLevodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease.
003237 (2001) Frédéric Calon [Canada] ; Nadia Lavertu [Canada] ; Anne-Marie Lemieux [Canada] ; Marc Morissette [Canada] ; Martin Goulet [Canada] ; Richard Grondin [Canada] ; Pierre J. Blanchet [Canada] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada]Effect of MPTP‐induced denervation on basal ganglia GABAB receptors: Correlation with dopamine concentrations and dopamine transporter
003440 (2000) Sophie Callier [Canada, France] ; Marc Morissette [Canada] ; Michelle Grbois [Canada] ; Thérèse Di Paolo [Canada]Stereospecific prevention by 17β‐estradiol of MPTP‐induced dopamine depletion in mice
003620 (1999) C M Anderson [Canada] ; W. Xiong ; J D Geiger ; J D Young ; C E Cass ; S A Baldwin ; F E ParkinsonDistribution of equilibrative, nitrobenzylthioinosine-sensitive nucleoside transporters (ENT1) in brain.
003861 (1998) P. Seeman [Canada] ; R. Corbett ; H H Van TolDopamine D4 receptors may alleviate antipsychotic-induced parkinsonism.
003868 (1998) P. Seeman [Canada] ; T. TallericoAntipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors.
003C90 (1996) F E Parkinson [Canada] ; J D GeigerEffects of iodotubercidin on adenosine kinase activity and nucleoside transport in DDT1 MF-2 smooth muscle cells.
003F01 (1996) J. M. Wilson [Canada] ; A. I. Levey [États-Unis] ; A. Rajput [Canada] ; L. Ang [Canada] ; M. Guttman [Canada] ; K. Shannak [Canada] ; H. B. Niznik [Canada] ; O. Hornykiewicz [Canada, Autriche] ; C. Pifl [Autriche] ; S. J. Kish [Canada]Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease
004650 (1992) M. Guttman [Canada]Dopamine receptors in Parkinson's disease
004680 (1991) F E Parkinson [Canada] ; A S ClanachanAdenosine receptors and nucleoside transport sites in cardiac cells.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Radioligand Assay" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Radioligand Assay" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Radioligand Assay
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022